Abramson, B. L., and S. M. Nelson. “PCSK9 Targeted Therapy to Lower Cholesterol and Reduce Cardiovascular Events”. Canadian Cardiology Today, vol. 1, no. 1, Mar. 2025, pp. 20–25, doi:10.58931/cct.2025.114.